Biofil Chemicals & Pharmaceuticals Share Price
Start SIP in Biofil Chemicals & Pharmaceuticals
Start SIPBiofil Chemicals & Pharmaceuticals Performance
Day Range
- Low 65
- High 68
52 Week Range
- Low 45
- High 79
- Open Price68
- Previous Close67
- Volume45261
Biofil Chemicals & Pharmaceuticals Investment Rating
-
Master Rating:
-
Biofil Chemicals & Pharmaceuticals has an operating revenue of Rs. 46.05 Cr. on a trailing 12-month basis. An annual revenue growth of 35% is outstanding, Pre-tax margin of 2% needs improvement, ROE of 3% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 6% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. It is currently FORMING a base in its weekly chart and is trading around 15% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 28 which is a POOR score indicating inconsistency in earnings, a RS Rating of 39 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 24 indicates it belongs to a strong industry group of Medical-Ethical Drugs and a Master Score of D is close to being the worst. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 8 | 15 | 5 | 17 | 2 | 14 |
| Operating Expenses Qtr Cr | 8 | 15 | 5 | 17 | 2 | 13 |
| Operating Profit Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 |
Biofil Chemicals & Pharmaceuticals Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 14
- Bearish Moving Average
- ___
- 2
- 20 Day
- ₹64.94
- 50 Day
- ₹64.88
- 100 Day
- ₹64.53
- 200 Day
- ₹62.22
- 20 Day
- ₹64.83
- 50 Day
- ₹65.11
- 100 Day
- ₹65.56
- 200 Day
- ₹63.11
Biofil Chemicals & Pharmaceuticals Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 67.39 |
| Second Resistance | 69.38 |
| Third Resistance | 70.78 |
| RSI | 51.73 |
| MFI | 66.44 |
| MACD Single Line | 0.09 |
| MACD | 0.15 |
| Support | |
|---|---|
| First Support | 64.00 |
| Second Support | 62.60 |
| Third Supoort | 60.61 |
Biofil Chemicals & Pharmaceuticals Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 49,710 | 3,069,095 | 61.74 |
| Week | 68,010 | 3,523,588 | 51.81 |
| 1 Month | 75,116 | 3,794,116 | 50.51 |
| 6 Month | 89,396 | 4,774,614 | 53.41 |
Biofil Chemicals & Pharmaceuticals Result Highlights
Biofil Chemicals & Pharmaceuticals Synopsis
NSE-Medical-Ethical Drugs
Biofil Chemicals belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 30.04 Cr. and Equity Capital is Rs. 16.27 Cr. for the Year ended 31/03/2023. Biofil Chemicals & Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 04/01/1985 and has its registered office in the State of Madhya Pradesh, India. Company’s Corporate Identification Number(CIN) is L24233MP1985PLC002709 and registration number is 002709.| Market Cap | 106 |
| Sales | 46 |
| Shares in Float | 0.86 |
| No of funds | 4 |
| Yield |
| Book Value | 5.84 |
| U/D Vol ratio | 1.7 |
| LTDebt / Equity | |
| Alpha | -0.05 |
| Beta | 1.62 |
Biofil Chemicals & Pharmaceuticals Shareholding Pattern
| Owner Name | Jun-24 | Mar-24 | Dec-23 | Sep-23 |
|---|---|---|---|---|
| Promoters | 46.82% | 46.82% | 46.82% | 46.82% |
| Foreign Portfolio Investors | 0.03% | |||
| Financial Institutions/ Banks | 0.04% | 0.04% | 0.04% | 0.04% |
| Individual Investors | 37.28% | 38.04% | 37.67% | 37.97% |
| Others | 15.86% | 15.07% | 15.47% | 15.17% |
Biofil Chemicals & Pharmaceuticals Management
| Name | Designation |
|---|---|
| Mr. Ramesh Shah | Chairman & Managing Director |
| Mr. Ketan Shah | Whole Time Director |
| Mr. Romil Shah | Non Executive Director |
| Mrs. Gayatri Padiyar | Ind. Non-Executive Director |
| Mr. Ashok Kumar Ramawat | Independent Director |
| Mr. Satish Beohar | Independent Director |
| Mrs. Shaila Jain | Independent Director |
Biofil Chemicals & Pharmaceuticals Forecast
Price Estimates
Biofil Chemicals & Pharmaceuticals Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2024-08-13 | Quarterly Results | |
| 2024-05-30 | Audited Results | |
| 2024-02-06 | Quarterly Results | |
| 2023-11-09 | Quarterly Results | |
| 2023-08-14 | Quarterly Results |
Biofil Chemicals & Pharmaceuticals FAQs
What is Share Price of Biofil Chemicals & Pharmaceuticals ?
Biofil Chemicals & Pharmaceuticals share price is ₹65 As on 07 September, 2024 | 23:34
What is the Market Cap of Biofil Chemicals & Pharmaceuticals ?
The Market Cap of Biofil Chemicals & Pharmaceuticals is ₹106.4 Cr As on 07 September, 2024 | 23:34
What is the P/E ratio of Biofil Chemicals & Pharmaceuticals ?
The P/E ratio of Biofil Chemicals & Pharmaceuticals is 167.8 As on 07 September, 2024 | 23:34
What is the PB ratio of Biofil Chemicals & Pharmaceuticals ?
The PB ratio of Biofil Chemicals & Pharmaceuticals is 5.8 As on 07 September, 2024 | 23:34